• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Late ventricular fibrillation following myocardial infarction is associated with increased risk of 1-year mortality

byPaary BalakumarandSimon Pan
January 12, 2026
in Cardiology, Chronic Disease, Emergency, Imaging and Intervention
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Late ventricular fibrillation after acute myocardial infarction is associated with a markedly increased risk of 1-year mortality among patients who survive to hospital discharge.

2. This excess mortality risk is significant in ST-segment elevation myocardial infarction but not clearly demonstrated in non-ST-segment elevation myocardial infarction.

Evidence Rating Level: 2 (Good)

Late ventricular fibrillation, defined as ventricular fibrillation occurring more than 48 hours after acute myocardial infarction, is uncommon in the contemporary reperfusion era, but its prognostic significance after hospital discharge remains uncertain. This nationwide retrospective cohort study used data from the Israeli Acute Coronary Syndrome Survey between 2000 and 2018 to evaluate the incidence of late in-hospital ventricular fibrillation and its association with 1-year mortality among patients with acute myocardial infarction who survived the index hospitalization. Among 14,280 patients with ST-segment elevation and non-ST-segment elevation myocardial infarction admitted to cardiac intensive care units, 118 patients developed late ventricular fibrillation, of whom 68 survived to discharge. Patients with late ventricular fibrillation had more severe clinical profiles, including higher Killip class, lower left ventricular ejection fraction, and more frequent cardiogenic shock and acute renal failure. Overall, 1-year mortality was substantially higher in patients with late ventricular fibrillation compared with those without. After multivariable adjustment, late ventricular fibrillation was independently associated with increased 1-year mortality, with this association remaining statistically significant in patients with ST-segment elevation myocardial infarction but not in those with non-ST-segment elevation myocardial infarction. These findings suggest that late ventricular fibrillation identifies a particularly high-risk subgroup of myocardial infarction survivors, especially among ST-segment elevation myocardial infarction patients, and highlight the need for improved post-discharge risk stratification and evaluation of preventive strategies.

Click here to read the study in BMJ Open

Image: PD

RELATED REPORTS

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: 1-year mortalitycardiologynon-ST segment elevation acute myocardial infarctionSTEMIventricular fibrillation
Previous Post

A guided mobile application may validly and efficiently assess sarcopenia and frailty in elderly patients

Next Post

Ultrasound-guided stellate ganglion block reduces postoperative visceral pain following laparoscopic hysterectomy

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Cardiology

Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function

March 3, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

Sodium-glucose cotransporter 2 inhibitors may improve left ventricular diastolic function in hypertrophic cardiomyopathy

February 17, 2026
Next Post
Social networks play key roles in parental vaccination decisions

Ultrasound-guided stellate ganglion block reduces postoperative visceral pain following laparoscopic hysterectomy

Placebo formulation impacts effectiveness of pain control in osteoarthritis

Infrapatellar fat pad glucocorticoid injections may not reduce pain or effusion volume in patients with knee osteoarthritis

Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Maternal smoking is associated with increased risk of sudden unexpected infant death
  • NVIDIA GTC 2026 unveils Isaac GR00T foundation model for surgical robotics
  • Mezagitimab appears safe and potentially effective for persistent immune thrombocytopenia
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.